A company founded in 2018, originated from the partnership and friendship between two Biotechnology experts with over 30 years of knowledge and expertise in the use of microorganisms and mammalian cells, in Research Institutes and in the Pharmaceutical Industry, to produce biological molecules of commercial interest.

We participated in the first biosimilar monoclonal antibody projects for therapeutic use in humans in Brazil, with international partners, as well as in the Marketing Authorization process for the first product in this category by a Brazilian industry. Our portfolio of clients and partners comprises the main players in the market for biological products for therapeutic use in Brazil.

We can assist your company according to your needs and based on our know-how and expertise, in a variety of aspects related to the development, production, investment and acquisition of innovative biological products or biosimilars, while ensuring compliance with regulatory requirements.